Cancers Review is an international, peer-reviewed journal dedicated to advancing knowledge in all areas of cancer research, prevention, diagnosis, treatment, and survivorship. The journal serves as a comprehensive platform for clinicians, researchers, and healthcare professionals working across oncology, molecular biology, pathology, pharmacology, immunology, epidemiology, medicinal sciences, and related disciplines.
Editorial and Peer-Review Process
All submitted manuscripts undergo a rigorous editorial and peer-review process to ensure scientific quality, originality, and relevance to the journal’s scope.
-
Initial Editorial Assessment: Each manuscript is evaluated by the editorial team to determine its suitability for the journal and its alignment with the aims and scope of Cancers Review. Manuscripts that fall outside the journal’s focus or raise ethical concerns, including plagiarism, self-plagiarism, or other forms of academic misconduct, may be rejected without external review.
-
Plagiarism Screening: To maintain the highest standards of academic integrity, all submissions are screened using CrossCheck powered by iThenticate before entering the peer-review process.
-
Peer Review: Manuscripts that successfully pass the initial evaluation are subjected to a rigorous peer-review process conducted by qualified experts in the relevant field. Authors typically receive a first decision within approximately 15-30 days.
Publication Timeline
The journal is committed to maintaining an efficient and transparent publication process. Current median processing times are:
| Editorial Stage | Median Time |
|---|---|
| Submission to First Decision | 7 Days |
| Submission to Decision After Review | 30 Days |
| Submission to Acceptance | 60 Days |
| Acceptance to Online Publication | 15 Days |
While many accepted manuscripts are published online promptly following final approval, the median time from acceptance to online publication is currently 15 days. In some cases, publication may require additional time to ensure balanced issue planning, thematic consistency, and diversity of published content.
Publication Frequency
Cancers Review is published twice a year, with issues released in June and December.
Article Processing Charges (APC)
Cancers Review does not charge any article processing fees for submissions in 2026. However, manuscripts requiring English language editing and proofreading may incur a nominal fee, determined by the length of the document
Digital Object Identifier (DOI)
Each article published in Cancers Review is assigned a unique Digital Object Identifier (DOI), ensuring permanent accessibility, discoverability, and reliable citation of scholarly content.
Indexing and Visibility
Cancers Review is indexed in Google Scholar, and other reputable academic databases, enhancing the visibility, accessibility, and impact of published research on a global scale.
Reviewer Recognition
The journal highly values the contributions of peer reviewers. Reviewers who provide timely and comprehensive review reports receive vouchers that entitle them to discounts on the APC of future publications in any Conscientia Beam journal.
Publication Ethics and Academic Integrity
Conscientia Beam is committed to maintaining the highest standards of publication ethics and academic integrity. The publisher enforces rigorous peer-review procedures and strict ethical policies to ensure the quality and credibility of the scientific record. Cases involving plagiarism, data fabrication or falsification, inappropriate authorship attribution, duplicate publication, or other forms of research misconduct are treated with the utmost seriousness and are addressed under a zero-tolerance policy.
To verify the originality of submitted manuscripts, all submissions are screened using iThenticate and evaluated against previously published literature. Through these measures, Cancers Review and Conscientia Beam strive to uphold transparency, accountability, and excellence in scholarly publishing.